molecular function |
| GO:0001965 | | G-protein alpha-subunit binding | | Interacting selectively and non-covalently with a G-protein alpha subunit. The alpha subunit binds a guanine nucleotide. |
| GO:0004930 | | G-protein coupled receptor activity | | Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. |
| GO:0004945 | | angiotensin type II receptor activity | | An angiotensin receptor activity that acts via Gi protein coupling and cGMP (NO) generation, and may also act via additional signaling mechanisms. |
| GO:0017046 | | peptide hormone binding | | Interacting selectively and non-covalently with any peptide with hormonal activity in animals. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0004871 | | signal transducer activity | | Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response. |
| GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
biological process |
| GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| GO:0007199 | | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger | | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by activation of guanylyl cyclase (GC) activity and a subsequent increase in the concentration of cyclic GMP (cGMP). |
| GO:0035932 | | aldosterone secretion | | The regulated release of aldosterone into the circulatory system. Aldosterone is a pregnane-based steroid hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney. |
| GO:0038166 | | angiotensin-activated signaling pathway | | The series of molecular signals generated as a consequence of angiotensin II binding to an angiotensin receptor on the surface of the cell, and proceeding with the activated receptor transmitting the signal to a heterotrimeric G-protein complex to initiate a change in cell activity. Ends with regulation of a downstream cellular process, e.g. transcription. |
| GO:0002033 | | angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure | | The process that increases the diameter of a blood vessel via the renin-angiotensin system. |
| GO:0002035 | | brain renin-angiotensin system | | The process in which an angiotensin-mediated signaling system present in the brain regulates the force with which blood passes through the circulatory system. |
| GO:0061049 | | cell growth involved in cardiac muscle cell development | | The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state. |
| GO:0007166 | | cell surface receptor signaling pathway | | A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| GO:0071549 | | cellular response to dexamethasone stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus. |
| GO:0006883 | | cellular sodium ion homeostasis | | Any process involved in the maintenance of an internal steady state of sodium ions at the level of a cell. |
| GO:0021695 | | cerebellar cortex development | | The process whose specific outcome is the progression of the cerebellar cortex over time, from its formation to the mature structure. The cerebellar cortex is a thin mantle of gray matter that covers the surface of each cerebral hemisphere. It has a characteristic morphology with convolutions (gyri) and crevices (sulci) that have specific functions. Six layers of nerve cells and the nerve pathways that connect them comprise the cerebellar cortex. Together, these regions are responsible for the processes of conscious thought, perception, emotion and memory as well as advanced motor function. |
| GO:0042416 | | dopamine biosynthetic process | | The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. |
| GO:0035640 | | exploration behavior | | The specific behavior of an organism in response to a novel environment or stimulus. |
| GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| GO:0035556 | | intracellular signal transduction | | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
| GO:0001822 | | kidney development | | The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. |
| GO:0060993 | | kidney morphogenesis | | Morphogenesis of a kidney. A kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine. |
| GO:0048147 | | negative regulation of fibroblast proliferation | | Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
| GO:0010459 | | negative regulation of heart rate | | Any process that stops, prevents or reduces the frequency or rate of heart contraction. |
| GO:0032304 | | negative regulation of icosanoid secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of an icosanoid from a cell. |
| GO:0051387 | | negative regulation of neurotrophin TRK receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of the neurotrophin TRK receptor signaling pathway. |
| GO:0010700 | | negative regulation of norepinephrine secretion | | Any process that decreases the frequency, rate or extent of the regulated release of norepinephrine. |
| GO:0030182 | | neuron differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a neuron. |
| GO:0090190 | | positive regulation of branching involved in ureteric bud morphogenesis | | Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:0050715 | | positive regulation of cytokine secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell. |
| GO:2001238 | | positive regulation of extrinsic apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
| GO:0072300 | | positive regulation of metanephric glomerulus development | | Any process that increases the rate, frequency or extent of metanephric glomerulus development, the progression of the metanephric glomerulus over time from its initial formation until its mature state. The metanephric glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney, or metanephros. |
| GO:0051000 | | positive regulation of nitric-oxide synthase activity | | Any process that activates or increases the activity of the enzyme nitric-oxide synthase. |
| GO:0032516 | | positive regulation of phosphoprotein phosphatase activity | | Any process that activates or increases the activity of a phosphoprotein phosphatase. |
| GO:0035815 | | positive regulation of renal sodium excretion | | Any process that increases the amount of sodium excreted in urine over a unit of time. |
| GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0042981 | | regulation of apoptotic process | | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
| GO:0035566 | | regulation of metanephros size | | Any process that modulates the size of a metanephric kidney. |
| GO:0001991 | | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | | The process in which angiotensinogen metabolites in the bloodstream modulate the force with which blood passes through the circulatory system. The process begins when renin is released and cleaves angiotensinogen. |
| GO:0042990 | | regulation of transcription factor import into nucleus | | Any process that modulates the frequency, rate or extent of the movement of a transcription factor from the cytoplasm to the nucleus. |
| GO:0002018 | | renin-angiotensin regulation of aldosterone production | | The process in which an increase in active angiotensin stimulates the adrenal cortices to secrete aldosterone. |
| GO:0010243 | | response to organonitrogen compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond. |
| GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
cellular component |
| GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |